SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013763
Filing Date
2023-08-08
Accepted
2023-08-08 08:01:58
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20230630x10q.htm   iXBRL 10-Q 1525132
2 EX-31.1 capr-20230630xex31d1.htm EX-31.1 10571
3 EX-31.2 capr-20230630xex31d2.htm EX-31.2 10284
4 EX-32.1 capr-20230630xex32d1.htm EX-32.1 5837
5 EX-32.2 capr-20230630xex32d2.htm EX-32.2 5798
  Complete submission text file 0001558370-23-013763.txt   5686516

Data Files

Seq Description Document Type Size
6 EX-101.SCH capr-20230630.xsd EX-101.SCH 44199
7 EX-101.CAL capr-20230630_cal.xml EX-101.CAL 38206
8 EX-101.DEF capr-20230630_def.xml EX-101.DEF 178359
9 EX-101.LAB capr-20230630_lab.xml EX-101.LAB 322549
10 EX-101.PRE capr-20230630_pre.xml EX-101.PRE 270300
47 EXTRACTED XBRL INSTANCE DOCUMENT capr-20230630x10q_htm.xml XML 850769
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 231149410
SIC: 2834 Pharmaceutical Preparations